Lopinavir - PDFSEARCH.IO - Document Search Engine

Lopinavir
Results: 160

#	Item
111	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ.  REYATAZ (atazanavir sulfate) Caps Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-03-16 16:23:59 Carbamates Organofluorides Bristol-Myers Squibb Pyridines Atazanavir Lopinavir/ritonavir Ritonavir Tenofovir Efavirenz Chemistry Organic chemistry Protease inhibitors
112	AIDS InfoNet[removed]www.aidsinfonet.org Fact Sheet Number 554[removed]DIARRHEA WHAT IS DIARRHEA? Add to Reading List Source URL: www.aidsinfonet.org Language: English - Date: 2014-02-05 12:43:05 Microbiology Diarrhea Lactobacillus acidophilus AIDS Lopinavir/ritonavir Nelfinavir Infectious diarrhea Wilderness acquired diarrhea Medicine Health Waterborne diseases
113	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-01-22 11:19:20 Lopinavir/ritonavir Lopinavir Antiretroviral drug Efavirenz Nevirapine Midazolam Nelfinavir Ritonavir Atazanavir Chemistry Organic chemistry Protease inhibitors
114	----------------------- WARNINGS AND PRECAUTIONS ---------------• Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1) • LEXIVA should be discon Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-02-14 16:20:44 Ritonavir Lopinavir Delavirdine Nelfinavir Antiretroviral drug Fosamprenavir Darunavir Atazanavir Protease inhibitors Chemistry Organic chemistry
115	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REYATAZ safely and effectively. See full prescribing information for REYATAZ.  REYATAZ (atazanavir sulfate) Caps Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-08-21 14:02:06 Carbamates Organofluorides Bristol-Myers Squibb Pyridines Atazanavir Lopinavir/ritonavir Ritonavir Tenofovir Efavirenz Chemistry Organic chemistry Protease inhibitors
116	Supplements 11, 12, & 14 draft labeling HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for IN Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-03-01 14:46:34 Non-nucleoside reverse transcriptase inhibitors Carbamates Pyridines Sulfonamides Darunavir Etravirine Lopinavir/ritonavir Ritonavir Antiretroviral drug Chemistry Organic chemistry Protease inhibitors
117	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PREZISTA safely and effectively. See Full Prescribing Information for PREZISTA. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-04-08 13:54:35 Carbamates Darunavir Sulfonamides Fixed dose combination Lopinavir/ritonavir Ritonavir Lopinavir Antiretroviral drug Protease inhibitors Chemistry Organic chemistry
118	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CRESTOR safely and effectively. See full prescribing information for CRESTOR. -------------------------------CONTRA Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-02-29 16:06:13 Cardiology Statins Sulfonamides Rosuvastatin Lopinavir/ritonavir Fenofibrate Low-density lipoprotein Atazanavir Familial hypercholesterolemia Chemistry Organic chemistry Protease inhibitors
119	----------------------- WARNINGS AND PRECAUTIONS ---------------  Certain drugs should not be coadministered with LEXIVA due to risk of serious or life-threatening adverse reactions. (5.1)  LEXIVA should be dis Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-02-22 15:55:20 Ritonavir Lopinavir Delavirdine Antiretroviral drug Nelfinavir Darunavir Lopinavir/ritonavir Protease inhibitors Chemistry Organic chemistry
120	1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-08-15 16:02:38 Non-nucleoside reverse transcriptase inhibitors Carbamates Pyridines Sulfonamides Darunavir Etravirine Lopinavir/ritonavir Ritonavir Atazanavir Chemistry Organic chemistry Protease inhibitors

UPDATE